The second most cited article titled “Matrix metalloproteinase-2-mediated occludin degradation and caveolin-1-mediated claudin-5 redistribution contribute to BBB damage in the early stage of ischemic stroke” was published in The Journal of Neuroscience. This evidence concerns the gene CLDN5 and ischemic stroke.